Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keiichi Morishita
Efficacy and Safety of Oxaliplatin, Bevacizumab and Oral S-1 for Advanced Recurrent Colorectal Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer
The Lancet Oncology
Oncology
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
Clinical Ovarian Cancer
FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Evaluation of Safety of FOLFOX4 Regimen in Patients With Advanced and Recurrent Colorectal Cancer
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Results of a Randomized and Controlled Clinical Trial Evaluating the Efficacy and Safety of Combination Therapy With Endostar and S-1 Combined With Oxaliplatin in Advanced Gastric Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Longterm Control of Advanced and Recurrent Gastric Cancer (ARGC) by S-1
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
